The Global Enzyme Linked Immunosorbent Assay Market Growth Accelerated By Increasing Prevalence Of Chronic Diseases
![]() |
Enzyme Linked Immunosorbent Assay Market |
Enzyme Linked Immunosorbent Assay or ELISA plays a crucial
role in detecting various chronic diseases. It is a biochemical technique used
mainly in immunology to detect the presence of antibodies and antigens in samples
like blood, serum and plasma. ELISA technique offers high sensitivity and
specificity for detecting diseases at an early stage. The global Enzyme Linked
Immunosorbent Assay Market is estimated to be valued at US$ 2118.92 Mn in 2023
and is expected to exhibit a CAGR of
5.1% over the forecast period 2023 to 2030, as highlighted in a new report
published by Coherent Market Insights.
Market key trends:
Increasing prevalence of chronic diseases like cancer, cardiovascular diseases,
diabetes and infectious diseases are the major factors fueling the growth of
the ELISA market. According to the estimates of WHO, chronic diseases accounted
for around 70% of all deaths worldwide in 2020. Moreover, adoption of sedentary
lifestyle and consumption of junk food has also contributed significantly
towards the rising cases of chronic illnesses.ELISA technique plays a pivotal
role in early detection of such diseases which can help in timely treatment.
Technological advancements in ELISA platforms have enabled development of
high-throughput automated system with improved sensitivity, specificity and
reproducibility. This has expanded the applications of ELISA in different
clinical diagnostic areas thus driving the market growth over the forecast
period.
Segment
Analysis
The global enzyme linked immunosorbent assay market is dominated by sandwich
ELISA segment which accounted for around 60% share in 2022. Sandwich ELISA is
widely used technique which detects antibodies or proteins in the sample. In
sandwich ELISA, two antibodies are used- one to capture the antigen onto the
surface and other linked to an enzyme to detect the bound antigen. This
technique offers high specificity and sensitivity for detection of various
biomolecules and hence is the most commonly used ELISA technique globally.
Key Takeaways
The global enzyme
linked immunosorbent assay market demand is expected to witness high growth
over the forecast period. The market growth can be attributed to factors such
as increasing prevalence of chronic and infectious diseases globally, rising
research activities in life science industry and growing demand for diagnostic
testing. The global Enzyme Linked Immunosorbent Assay Market is estimated to be
valued at US$ 2118.92 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over
the forecast period 2023 to 2030.
Regional analysis
North America dominated the global market and accounted for over 35% market
share in 2022 due to increasing research funding, advanced healthcare
infrastructure and presence of leading market players in the region. Asia
Pacific is expected to witness fastest growth during the forecast period
attributed to growing healthcare expenditure, rising geriatric population,
expanding biopharmaceutical industry and increasing awareness.
Key players
Key players operating in the enzyme linked immunosorbent assay market are
Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific,
Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative
Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.
Get more insights on this topic: https://www.newswirestats.com/enzyme-linked-immunosorbent-assay-market-industry-insights-trendsenzyme-linked-immunosorbent-assay-market-2023-2030/
Comments
Post a Comment